Contingency nature of Helicobacter bizzozeronii oxygen-insensitive NAD(P)H-nitroreductase (HBZC1-00960) and its role in metronidazole resistance

Veterinary Research

Volumn 44, Issue 1, 2013, Pages

  Kondadi, Pradeep Kumar ^a   Pacini, Claudia ^a   Revez, Joana ^a   Hänninen, Marja Liisa ^a   Rossi, Mirko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HELICOBACTER; HELICOBACTER BIZZOZERONII; HELICOBACTER PYLORI;

ANTIINFECTIVE AGENT; AROMATIC NADH-DEPENDENT NITROREDUCTASE; BACTERIAL PROTEIN; METRONIDAZOLE; NITROREDUCTASE; AROMATIC NADH DEPENDENT NITROREDUCTASE;

AMINO ACID SEQUENCE; ANIMAL; ANTIBIOTIC RESISTANCE; CHEMISTRY; DOG; DRUG EFFECTS; GENETICS; HELICOBACTER; HUMAN; METABOLISM; MUTATION; SEQUENCE ALIGNMENT; VETERINARY; ANIMAL DISEASE; ARTICLE; DRUG EFFECT;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DOGS; DRUG RESISTANCE, BACTERIAL; HELICOBACTER; HUMANS; METRONIDAZOLE; MUTATION; NITROREDUCTASES; SEQUENCE ALIGNMENT;

EID: 84880111392     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-44-56     Document Type: Article

References (32)

1. Helicobacter pylori infection. Suerbaum S, Michetti P, N Engl J Med 2002 347 1175 1186 10.1056/NEJMra020542 12374879
2. Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Haesebrouck F, Pasmans F, Flahou B, Chiers K, Baele M, Meyns T, Decostere A, Ducatelle R, Clin Microbiol Rev 2009 22 202 223 10.1128/CMR.00041-08 19366912
3. The clinical aspects of Helicobacter heilmannii infection in children with dyspeptic symptoms. Iwanczak B, Biernat M, Iwanczak F, Grabinska J, Matusiewicz K, Gosciniak G, J Physiol Pharmacol 2012 63 133 136 22653899
4. Helicobacter heilmannii related gastric ulcer in childhood. Sykora J, Hejda V, Varvarovska J, Stozicky F, Gottrand F, Siala K, J Pediatr Gastroenterol Nutr 2003 36 410 413 10.1097/00005176-200303000-00022 12604985 (Pubitemid 39274619)
5. Helicobacter heilmannii gastroduodenal disease and clinical aspects in children with dyspeptic symptoms. Sykora J, Hejda V, Varvarovska J, Stozicky F, Siala K, Schwarz J, Acta Paediatr 2004 93 707 709 10.1111/j.1651-2227.2004. tb03001.x 15174799 (Pubitemid 38570243)
6. Characterization of a culturable "Gastrospirillum hominis" (Helicobacter heilmannii) strain isolated from human gastric mucosa. Andersen LP, Boye K, Blom J, Holck S, Norgaard A, Elsborg L, J Clin Microbiol 1999 37 1069 1076 10074528 (Pubitemid 29140616)
7. Characterization of multiple Helicobacter bizzozeronii isolates from a Finnish patient with severe dyspeptic symptoms and chronic active gastritis. Kivistö R, Linros J, Rossi M, Rautelin H, Hänninen ML, Helicobacter 2010 15 58 66 10.1111/j.1523-5378.2009.00730.x 20302591
8. In vitro antimicrobial susceptibility testing of Helicobacter felis, H. bizzozeronii, and H. salomonis. Van den Bulck K, Decostere A, Gruntar I, Baele M, Krt B, Ducatelle R, Haesebrouck F, Antimicrob Agents Chemother 2005 49 2997 3000 10.1128/AAC.49.7.2997-3000.2005 15980383 (Pubitemid 40917625)
9. Antimicrobial susceptibility pattern of Helicobacter suis strains. Vermoote M, Pasmans F, Flahou B, Van Deun K, Ducatelle R, Haesebrouck F, Vet Microbiol 2011 153 339 342 10.1016/j.vetmic.2011.06.009 21733643
10. Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature. Kato S, Ozawa K, Sekine H, Ohyauchi M, Shimosegawa T, Minoura T, Iinuma K, J Gastroenterol 2005 40 94 97 10.1007/s00535-004-1499-2 15692795 (Pubitemid 40796338)
11. An unusual case of gastric erosions. Jothimani DK, Zanetto U, Owen RJ, Lawson AJ, Wilson PG, Gut 2009 58 1669 1708 10.1136/gut.2008.176065 19923347
12. Helicobacter heilmannii reinfection in a Helicobacter pylori negative adolescent: a 4-year follow-up. Siala K, Sykora J, Hes O, Varvarovska J, Pazdiora P, J Clin Gastroenterol 2007 41 221 222 10.1097/01.mcg.0000212605. 13348.2c 17245224 (Pubitemid 46148667)
13. Helicobacter heilmannii gastritis in a young patient with a pet. Roehrl MH, Hernandez M, Yang S, Christensen TG, Morera C, Wang JY, Gastrointest Endosc 2012 76 421 422 10.1016/j.gie.2012.03.1403 22817795
14. Culture of a gastric non-Helicobacter pylori Helicobacter from the stomach of a 14-year-old girl. Wuppenhorst N, Von Loewenich F, Hobmaier B, Vetter-Knoll M, Mohadjer S, Kist M, Helicobacter 2013 18 1 5 10.1111/j.1523-5378.2012.00990.x 23067246
15. Microevolution of a zoonotic Helicobacter population colonizing the stomach of a human host before and after failed treatment. Schott T, Kondadi PK, Hanninen ML, Rossi M, Genome Biol Evol 2012 4 1310 1315 10.1093/gbe/evs107 23196968
16. A redox basis for metronidazole resistance in Helicobacter pylori. Kaakoush NO, Asencio C, Megraud F, Mendz GL, Antimicrob Agents Chemother 2009 53 1884 1891 10.1128/AAC.01449-08 19223619
17. Is the molecular basis of metronidazole resistance in microaerophilic organisms understood? Mendz GL, Mégraud F, Trends Microbiol 2002 10 370 375 10.1016/S0966-842X(02)02405-8 12160635 (Pubitemid 34876798)
18. Culture and characteristics of Helicobacter bizzozeronii, a new canine gastric Helicobacter sp. Hänninen ML, Happonen I, Saari S, Jalava K, Int J Syst Bacteriol 1996 46 160 166 10.1099/00207713-46-1-160 8573490 (Pubitemid 26030486)
19. Identification and characterization of a lipopolysaccharide alpha2,3-sialyltransferase from the human pathogen Helicobacter bizzozeronii. Kondadi PK, Rossi M, Twelkmeyer B, Schur MJ, Li J, Schott T, Paulin L, Auvinen P, Hänninen ML, Schweda EK, Wakarchuk W, J Bacteriol 2012 194 2540 2550 10.1128/JB.00126-12 22408169
20. Comparative genomics of Helicobacter pylori and the human-derived Helicobacter bizzozeronii CIII-1 strain reveal the molecular basis of the zoonotic nature of non-pylori gastric Helicobacter infections in humans. Schott T, Kondadi PK, Hänninen ML, Rossi M, BMC Genomics 2011 12 534 10.1186/1471-2164-12-534 22039924
21. European Committee on Antimicrobial Susceptibility Testing. Clinical Breakpoints http://www.eucast.org/clinical-breakpoints/
22. Evidence for conserved function of gamma-glutamyltranspeptidase in Helicobacter genus. Rossi M, Bolz C, Revez J, Javed S, El-Najjar N, Anderl F, Hyytiainen H, Vuorela P, Gerhard M, Hänninen ML, PLoS One 2012 7 30543 10.1371/journal.pone.0030543 22348013
23. Cloning and allelic exchange mutagenesis of two flagellin genes of Helicobacter felis. Josenhans C, Ferrero RL, Labigne A, Suerbaum S, Mol Microbiol 1999 33 350 362 10.1046/j.1365-2958.1999.01478.x 10411751 (Pubitemid 29322521)
24. Determining mutation rates in bacterial populations. Rosche WA, Foster PL, Methods 2000 20 4 17 10.1006/meth.1999.0901 10610800 (Pubitemid 30119596)
25. Fluctuation analysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbrück fluctuation analysis. Hall BM, Ma CX, Liang P, Singh KK, Bioinformatics 2009 25 1564 1565 10.1093/bioinformatics/ btp253 19369502
26. Optimal therapy for Helicobacter pylori infections. Rimbara E, Fischbach LA, Graham DY, Nat Rev Gastroenterol Hepatol 2011 8 79 88 10.1038/nrgastro.2010. 210 21293508
27. Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania. Kupcinskas L, Rasmussen L, Jonaitis L, Kiudelis G, Jorgensen M, Urbonaviciene N, Tamosiunas V, Kupcinskas J, Miciuleviciene J, Kadusevicius E, Berg D, Andersen LP, APMIS 2013 121 431 436 10.1111/apm.12012 23078193
28. Recent insights into antibiotic resistance in Helicobacter pylori eradication. Wu W, Yang Y, Sun G, Gastroenterol Res Pract 2012 2012 723183 22829809
29. Two amino acids mutation of ferric uptake regulator determines Helicobacter pylori resistance to metronidazole. Tsugawa H, Suzuki H, Satoh K, Hirata K, Matsuzaki J, Saito Y, Suematsu M, Hibi T, Antioxid Redox Signal 2011 14 15 23 10.1089/ars.2010.3146 20518707
30. Point mutations in Helicobacter pylori's fur regulatory gene that alter resistance to metronidazole, a prodrug activated by chemical reduction. Choi SS, Chivers PT, Berg DE, PLoS One 2011 6 18236 10.1371/journal.pone.0018236 21464913
31. Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori. Olekhnovich IN, Goodwin A, Hoffman PS, FEBS J 2009 276 3354 3364 10.1111/j.1742-4658.2009.07060. x 19438716
32. Phase variable genes of Campylobacter jejuni exhibit high mutation rates and specific mutational patterns but mutability is not the major determinant of population structure during host colonization. Bayliss CD, Bidmos FA, Anjum A, Manchev VT, Richards RL, Grossier JP, Wooldridge KG, Ketley JM, Barrow PA, Jones MA, Tretyakov MV, Nucleic Acids Res 2012 40 5876 5889 10.1093/nar/gks246 22434884